Here are 5 stocks that are buys right here, right now

Here are 5 stocks that are buys right here, right now


CNBC Investing Club with Jim Cramer

Rob Kim | NBCUniversal

Let’s say you just joined the Club, and you are trying to figure out which stocks we think are buyable right now, right here. Ideally, what I would like members to be thinking about is a companion portfolio of up to a dozen stocks to a market index fund position — something we recommend for investors just starting to manage their own money. Your own portfolio. Curated by us. Selected by you. More than 12 names, unless you’re a stock junkie like me, might be too hard to stay on top. Remember, buy and homework is my motto, not buy and hold and forget about it.

The question is: Which stocks would I buy right now? There are some in our 33-company portfolio that are just too high to recommend — and some, because of changes in circumstances are just too low, correctly low, and going lower like Salesforce after Wednesday evening’s quarter. We have a tough market. But I see stocks that are calling to me and saying it’s a good level to start. Not a single stock should be bought all at once. That’s a fool’s errand in a market that has developed a downward bias as we wrap up the month.



Source

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to  billion
Health

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to $12 billion

A startup widely known as “ChatGPT for doctors” raised a new funding round that values the company at $12 billion. OpenEvidence, based in Miami, Florida, closed a $250 million financing, led by Thrive Capital and DST, the company told CNBC. The startup first raised outside capital in February, when it reeled in $75 million from […]

Read More
Another alliance of health care and AI signals why pharma stocks should be back in favor
Health

Another alliance of health care and AI signals why pharma stocks should be back in favor

Bristol Myers Squibb and Microsoft ‘s new partnership aimed at accelerating early detection of lung cancer marks the latest way health care and artificial intelligence are rapidly intersecting. Bristol Myers said on Tuesday it will work with Microsoft’s AI-powered radiology platform to develop and launch imaging algorithms. These new tools, which can be used to […]

Read More
Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry
Health

Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry

US President Donald Trump arrives for an announcement in the Roosevelt Room of the White House in Washington, DC, US, on Friday, Dec. 19, 2025. Will Oliver | Bloomberg | Getty Images Drug pricing. Looming patent cliffs. Dealmaking. The first year of Trump 2.0. Those are among the themes that dominated conversations last week as drugmakers […]

Read More